Jake Y. Henry - Concepedia

Concepedia

Author

Jake Y. Henry

University College London ORCID

Also Known As

Henry, J, Henry, J. -Y., J Henry, J Y Henry, J. Henry, J. Y. Henry, J.-Y. HENRY, J.-Y. Henry, J.Y. Henry, Jake Henry

70

Publications

8.1K

Citations

23

H-Index

61

Concepts

All Affiliations

University College London London Cancer Garvan Institute of Medical Research CRUK Lung Cancer Centre of Excellence The Francis Crick Institute

JY

About

Jake Y. Henry is an author at University College London specializing in medicine, immunology, and cell biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	4.9K
2	Cell Biology	6	6	3.4K
3	Health Sciences	1	1	16
4	Allergy	1	1	71
5	Cellular Therapies	1	1	16

Jake Y. Henry

×

26

Publications

8.1K

Citations

23

H-Index

	Year	Citations
Clonal neoantigens elicit T cell immunoreactivity and sensitivity to immune checkpoint blockade Nicholas McGranahan, Andrew J.S. Furness, Rachel Rosenthal, Science T-regulatory CellImmunologyPathologyRegulatory T CellsT Cell Immunoreactivity	2016	3K
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma Tyler R. Simpson, Fubin Li, Welby Montalvo-Ortiz, The Journal of Experimental Medicine	2013	1.4K
Neoantigen-directed immune escape in lung cancer evolution Rachel Rosenthal, Elizabeth Larose Cadieux, Roberto Salgado, Nature ImmunologyImmunoeditingBronchial NeoplasmLung CancerMedicine	2019	945
Fc Effector Function Contributes to the Activity of Human Anti-CTLA-4 Antibodies Frederick Arce Vargas, Andrew J.S. Furness, Kevin Litchfield, Cancer Cell	2018	563
Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors Frederick Arce Vargas, Andrew J.S. Furness, Isabelle Solomon, Immunity	2017	425
The anti-cancer agents lenalidomide and pomalidomide inhibit the proliferation and function of T regulatory cells Christine Galustian, B Meyer, Marie‐Christine Labarthe, Cancer Immunology Immunotherapy Anti-cancer AgentsCancer ImmunosurveillanceMedicineT-regulatory CellImmunology	2008	384
The Heterogeneity of Ly6Chi Monocytes Controls Their Differentiation into iNOS+ Macrophages or Monocyte-Derived Dendritic Cells Shinelle Menezes, Daisy Melandri, Giorgio Anselmi, Immunity	2016	282
CD25-Treg-depleting antibodies preserving IL-2 signaling on effector T cells enhance effector activation and antitumor immunity Isabelle Solomon, Maria Amann, Anne Goubier, Nature Cancer Cancer ImmunosurveillanceT-regulatory CellImmunologyTumor ImmunityRegulatory T Cells	2020	184
The T cell differentiation landscape is shaped by tumour mutations in lung cancer Ehsan Ghorani, James L. Reading, Jake Y. Henry, Nature Cancer Somatic VariantTumor HeterogeneityMedicineTumour MutationsPathology	2020	99
Immune Surveillance in Clinical Regression of Preinvasive Squamous Cell Lung Cancer Adam Pennycuick, Vitor H. Teixeira, Khalid AbdulJabbar, Cancer Discovery	2020	92

Page 1